Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
21.04
+0.09 (0.43%)
At close: Mar 6, 2026, 4:00 PM EST
21.05
+0.01 (0.05%)
After-hours: Mar 6, 2026, 7:51 PM EST
Immunome Market Cap
Immunome has a market cap or net worth of $2.38 billion as of March 6, 2026. Its market cap has increased by 187.93% in one year.
Market Cap
2.38B
Enterprise Value
1.73B
1-Year Change
187.93%
Ranking
Category
Stock Price
$21.04
Market Cap Chart
Since the IPO on October 2, 2020, Immunome's market cap has increased from $111.39M to $2.38B, an increase of 2,036.91%. That is a compound annual growth rate of 75.80%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 2.38B | 0.44% |
| Dec 31, 2025 | 2.37B | 257.53% |
| Dec 31, 2024 | 662.87M | 44.98% |
| Dec 29, 2023 | 457.21M | 1,605.70% |
| Dec 30, 2022 | 26.80M | -82.91% |
| Dec 31, 2021 | 156.82M | 53.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Apellis Pharmaceuticals | 2.57B |
| Telix Pharmaceuticals | 2.56B |
| Travere Therapeutics | 2.51B |
| Wave Life Sciences | 2.47B |
| Dyne Therapeutics | 2.45B |
| Tango Therapeutics | 2.42B |
| Disc Medicine | 2.33B |
| Adaptive Biotechnologies | 2.29B |